Results 301 to 310 of about 3,251,205 (352)

Use of cell-free DNA in early detection of lung cancer: a proof-of concept study. [PDF]

BMC Cancer
White LL, Maiyani M, Quintana LM, Powers JD, Nichols LE, Dollar B, Bedoy R, Martinez AE, Feigelson HS.   +8 more
europepmc   +1 more source

Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myeloma. [PDF]

Hemasphere
Baker C, Hill E, Kazandjian D, Papadimitriou M, Durante M, Pandey A, Ziccheddu B, Jelinek T, Coffey D, Walker B, Young R, Maclachlan K, Korde N, Parkinson N, Goldstein ZR, Runnels A, Hooper WF, Landau D, Robine N, Maura F, Landgren O, Diamond B.   +21 more
europepmc   +1 more source

Extraction of Cell-Free DNA

The Journal of Molecular Diagnostics
Simone K. Terp, Inge S. Pedersen, Malene P. Stoico   +2 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living

Trends in Molecular Medicine, 2020
Cell-free DNA (cfDNA) is evolving into a widely used prognostic and predictive biomarker, particularly in oncology. However, its versatile clinical use precedes a profound understanding of the underlying biology of cfDNA release.
Ellen Heitzer, Michael Speicher
exaly   +2 more sources

Cell-free DNA

Anais do 6º Simpósio de Saúde: Saúde 4.0 - Tecnologia e Inovação, 2023
O DNA livre de células, ou cfDNA, tem sido cada vez mais reconhecido como um biomarcador importante em diversas áreas da medicina.
Diogo Barcelos Almeida, Bárbara Stefanie de Souza Scodeler, Kelly Dos Santos Gonçalves, Maria Júlia Sá, Leiridiane Martins, Gabrielle Alves de Paiva, André Luís Braghini Sá   +6 more
openaire   +2 more sources

Cell-Free DNA in Dermatology Research

Journal of Investigative Dermatology, 2022
In various diseases, particularly cancer, cell-free DNA (cfDNA) has been widely studied as a marker of disease prognosis or to facilitate the detection of therapeutic targets. In dermatology, most studies have focused on melanoma; other skin diseases such as vascular malformations and psoriasis have also been examined. Genetic alterations unique to the
Jennifer M. Wiggins, Saim Ali, David Polsky   +2 more
openaire   +2 more sources

Epigenetics, fragmentomics, and topology of cell-free DNA in liquid biopsies

Science, 2021
Enhancing liquid biopsies Liquid biopsies, analyses of cell-free DNA that circulates in the blood, can be used in prenatal testing, oncology, and to monitor organ transplant recipients. Lo et al. review the nongenetic information that can be gleaned from
Y. Lo, D. S. Han, P. Jiang, R. Chiu
semanticscholar   +1 more source

Cell-free DNA: Preanalytical variables

Clinica Chimica Acta, 2015
Since the discovery of cell-free DNA (cfDNA) in human blood, most studies have focused on diagnostic and prognostic uses of these markers for solid tumors. Except for some prenatal tests and BEAMing, cfDNA analysis has not yet been translated to clinical practice and routine application appears distant. This can be attributed to overlapping factors: (i)
Abel Jacobus Bronkhorst, Janine Aucamp, Piet J. Pretorius   +2 more
openaire   +3 more sources

Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.

Trends in Molecular Medicine, 2021
Liquid biopsies, in particular, analysis of cell-free DNA (cfDNA), have emerged as a promising noninvasive diagnostic approach in oncology. Abnormal distribution of DNA methylation is one of the hallmarks of many cancers and methylation changes occur ...
Hui‐yan Luo, Wei Wei, Ziyi Ye, J. Zheng, Rui-hua Xu   +4 more
semanticscholar   +1 more source